Pentazocine induced myocutaneous sclerosis.

Area of Science:

• Dermatology
• Neurology
• Rheumatology

Background:

• Parenteral administration of pentazocine, a potent analgesic, can lead to adverse effects.
• Myocutaneous sclerosis is a known, albeit rare, complication associated with pentazocine use.

Observation:

• A patient presented with myocutaneous sclerosis following aggressive parenteral pentazocine administration.
• The patient exhibited typical dermatopathologic and myopathic abnormalities.
• Unique features included brachial plexus neuropathy and soft tissue calcification.

Findings:

• The case demonstrates that pentazocine-induced myocutaneous sclerosis can present with neurological and calcific complications.
• Brachial plexus neuropathy and soft tissue calcification are not commonly reported in this condition.

Implications:

• This case underscores the importance of careful consideration and monitoring when prescribing pentazocine for long-term pain management.
• Clinicians should be aware of the potential for severe and atypical complications.
• Further research may be warranted to elucidate the mechanisms behind these unique manifestations.